Effect of a single vaginal administration of levonorgestrel in Carraguard® gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception

Contraception

Volumn 76, Issue 2, 2007, Pages 111-116

  Brache, Vivian ^a   Croxatto, Horacio ^b   Sitruk Ware, Regine ^c   Maguire, Robin ^c   Montero, Juan Carlos ^b   Kumar, Narender ^c   Salvatierra, Ana Maria ^b   Tejada, Ana Sofia ^a   Cochón, Leila ^a   Forcelledo, María Luisa ^b   Lahteenmaki, Pekka ^c   Alvarez, Francisco ^a   Faundes, Anibal ^a  

^a PROFAMILIA   (Dominican Republic)

^b Instituto Chileno de Medicina Reproductiva   (Chile)

^c POPULATION COUNCIL   (United States)

Author keywords

Emergency contraception; Levonorgestrel; Microbicides; Ovarian function; Vaginal administration

Indexed keywords

ESTRADIOL; LEVONORGESTREL; LUTEINIZING HORMONE; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EMERGENCY CONTRACEPTION; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MULTICENTER STUDY; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY INSUFFICIENCY; OVULATION; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TRANSVAGINAL ECHOGRAPHY;

ADMINISTRATION, INTRAVAGINAL; ADULT; CONTRACEPTION, POSTCOITAL; CONTRACEPTIVE AGENTS, FEMALE; CROSS-OVER STUDIES; FEMALE; HUMANS; LEVONORGESTREL; MENSTRUAL CYCLE; OVARIAN FOLLICLE; OVULATION;

EID: 34447526229     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.04.005     Document Type: Article

References (26)

1. Baba M., Nakajima M., Schols D., Pauwels R., Balzarini J., and De Clercq E. Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. Antiviral Res 9 (1988) 335-343
2. Pearce-Pratt R., and Phillips D.M. Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of HIV-1. Biol Reprod 54 (1996) 173-182
3. Zacharopoulos V.R., and Phillips D.M. Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clin Diagn Lab Immunol 4 (1997) 465-468
4. Jerse A.E. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect Immun 67 (1999) 5699-5708
5. Maguire R., Bergman N., and Phillips D.M. Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization. Sex Transm Dis 28 (2001) 259-265
6. Spencer S.E., Valentin-Bon I.E., Whaley K., and Jerse A.E. Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model. J Infect Dis 189 (2004) 410-419
7. Elias C.J., Coggins C., Alvarez F., et al. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan. Contraception 56 (1997) 387-389
8. Coggins C., Blanchard K., Alvarez F., et al. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide. Sex Transm Infect 76 (2000) 480-483
9. Kilmarx P.H., van de Wilgert J.H., Chaikummao S., et al. Safety and acceptability of the candidate microbicide Carraguard in Thai women: findings from a Phase II clinical trial. J Acquir Immune Defic Syndr 43 (2006) 327-334
10. Sitruk-Ware R, Brache V, Maguire R, et al. Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard® gel: a new formulation for "dual protection" contraception. Contraception 2007;75:454-60.
11. Wilcox A.J., Weinberg C.R., and Baird D.D. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy and sex of the baby. N Engl J Med 333 (1995) 1517-1521
12. Croxatto H.B., Brache V., Pavez M., et al. Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75 mg dose given on the days preceding ovulation. Contraception 70 (2004) 442-450
13. Massai R., Forcelledo M.L., Brache V., et al. Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study. Hum Reprod 22 (2007) 434-439
14. Johansson E., Brache V., Alvarez F., et al. Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women. Hum Reprod 17 (2002) 1472-1476
15. Tremblay D., Gainer E., and Ulmann A. The pharmacokinetics of 750 μg levonorgestrel after administration of one single dose or two doses at 12- or 24-h interval. Contraception 64 (2001) 327-331
16. Kook K., Gabelnick H., and Duncan G. Pharmacokinetics of levonorgestrel 0.75 mg tablets. Contraception 66 (2002) 73-76
17. Alvarez F., Faundes A., Johansson E., and Coutinho E. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills. Fertil Steril 40 (1983) 120-123
18. Kives S., Hahn P., White E., Stanczyk F.Z., and Reid R. Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration. Contraception 71 (2005) 197-201
19. Devoto L., Fuentes A., Palomino A., et al. Pharmacokinetics and endometrial tissue levels of levonorgestrel alter administration of a single 1.5-mg dose by the oral and vaginal route. Fertil Steril 84 (2005) 46-51
20. De Ziegler D., Bulletti C., De Monstier B., and Jaaskelainen A.S. The first uterine pass effect. Ann N Y Acad Sci 828 (1997) 291-299
21. Roumen F.J.M.E., and Dieben T.O.M. Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive. Fertil Steril 85 (2006) 57-62
22. Alexander N.J., Baker E., Kaptein M., Karck U., Miller L., and Zampaglione E. Why consider vaginal drug administration?. Fertil Steril 82 (2004) 1-12
23. Von Hertzen H., Piaggio G., Ding J., et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 360 (2002) 1803-1810
24. WHO Task Force on Postovulatory Methods of Fertility Regulation. Efficacy and side effects of immediate postcoital levonorgestrel used repeatedly for contraception. Contraception 61 (2000) 303-308
25. Dupont S., Webber J., Dass K., and Thornton S. Emergency contraceptive pill (ECP) and sexual risk behaviour. Int J STD AIDS 13 (2002) 482-485
26. Fairhurst K., Ziebland S., Wyke S., Seaman P., and Glasier A. Emergency contraception: why can't you give it away? Qualitative findings from an evaluation of advanced provision of emergency contraception. Contraception 70 (2004) 25-29